0001209191-18-014675.txt : 20180228
0001209191-18-014675.hdr.sgml : 20180228
20180228184031
ACCESSION NUMBER: 0001209191-18-014675
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAN OORT DOUGLAS M
CENTRAL INDEX KEY: 0001518733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 18653639
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-26
0
0001077183
NEOGENOMICS INC
NEO
0001518733
VAN OORT DOUGLAS M
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
33913
0
1
0
0
Chairman and CEO
Common Stock
187500
I
Conundrum Capital Partners
Common Stock
1832985
D
Stock Option (Right to Buy)
7.15
2017-04-20
2021-04-20
Common Stock
472527
472527
D
Stock Option (Right to Buy)
7.52
2018-04-28
2022-04-28
Common Stock
500000
500000
D
Restricted Stock
0.00
2018-05-25
Common Stock
197042
197042
D
Stock Option (Right to Buy)
8.03
2018-02-26
4
A
0
636000
8.03
A
2019-02-26
2023-02-26
Common Stock
636000
636000
D
Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Conundrum Capital Partners, LLC
Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
Restricted stock will vest as follows; 65,680 units will vest on May 25, 2018 and 65,681 units will vest on May 25, 2019 and 2020.
These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.
On February 26, 2018, Mr. VanOort was granted 636,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
/s/ Douglas M. VanOort
2018-02-28